Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients

被引：0
|
作者：
Andreana De Mauri
Matteo Vidali
Doriana Chiarinotti
Giorgio Bellomo
Roberta Rolla
机构：
[1] “Maggiore della Carità” University Hospital,Nephrology and Dialysis Unit
[2] Amedeo Avogadro University of Eastern Piedmont,Department of Health Sciences
[3] “Maggiore della Carità” University Hospital,Clinical Chemistry Laboratory
来源：
Journal of Nephrology | 2019年 / 32卷
关键词：
Lipoprotein-associated phospholipase A2; Cardiovascular disease; Hemodialysis; Mortality; Atherosclerosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 288
页数：5
相关论文
共 50 条
  • [1] Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients
    De Mauri, Andreana
    Vidali, Matteo
    Chiarinotti, Doriana
    Bellomo, Giorgio
    Rolla, Roberta
    JOURNAL OF NEPHROLOGY, 2019, 32 (02) : 283 - 288
  • [2] Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients
    Rolla, Roberta
    De Mauri, Andreana
    Valsesia, Ambra
    Vidali, Matteo
    Chiarinotti, Doriana
    Bellomo, Giorgio
    JOURNAL OF NEPHROLOGY, 2015, 28 (06) : 749 - 755
  • [3] Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients
    Roberta Rolla
    Andreana De Mauri
    Ambra Valsesia
    Matteo Vidali
    Doriana Chiarinotti
    Giorgio Bellomo
    Journal of Nephrology, 2015, 28 : 749 - 755
  • [4] Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study
    Lin, Lin
    Teng, Jie
    Shi, Yiqin
    Xie, Qiwen
    Shen, Bo
    Xiang, Fangfang
    Cao, Xuesen
    Ding, Xiaoqiang
    Xu, Xialian
    Zhang, Zhen
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [5] The Use of Lipoprotein-Associated Phospholipase A2 in a Chinese Population to Predict Cardiovascular Events
    Xi Hui
    Cheng Guan Liang
    Hu Fei Fei
    Li Song Nan
    Deng Xuan
    Zhou Yong
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2022, 35 (03) : 206 - +
  • [6] Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease
    Maiolino, Giuseppe
    Lenzini, Livia
    Pedon, Luigi
    Cesari, Maurizio
    Seccia, Teresa Maria
    Frigo, Anna Chiara
    Rossitto, Giacomo
    Caroccia, Brasilina
    Rossi, Gian Paolo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2015, 16 (01) : 29 - 36
  • [7] Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular diseases
    Siekmeier, Ruediger
    Grammer, Tanja B.
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Koenig, Wolfgang
    Maerz, Winfried
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2010, 34 (04): : 217 - 222
  • [8] LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 AND STROKE
    Alvarez-Perez, F. J.
    Verde, I.
    REVISTA DE NEUROLOGIA, 2009, 49 (02) : 88 - 94
  • [9] Lipoprotein-associated phospholipase A2 predicts cardiovascular death in patients on maintenance hemodialysis: a 7-year prospective cohort study
    Lin Lin
    Jie Teng
    Yiqin Shi
    Qiwen Xie
    Bo Shen
    Fangfang Xiang
    Xuesen Cao
    Xiaoqiang Ding
    Xialian Xu
    Zhen Zhang
    Lipids in Health and Disease, 23
  • [10] Chemiluminescence immunoassay for sensing lipoprotein-associated phospholipase A2 in cardiovascular risk evaluation
    Chen, Jialing
    Zhang, Huisheng
    Chen, Wenwen
    CLINICA CHIMICA ACTA, 2019, 488 : 143 - 149
12345